酒石酸福莫特罗

更新时间：2024-01-04 13:08:53

酒石酸福莫特罗结构式	常用名	酒石酸福莫特罗	英文名	Arformoterol tartrate
	CAS号	200815-49-2	分子量	494.492
	密度	N/A	沸点	603.2ºC at 760mmHg
	分子式	C₂₃H₃₀N₂O₁₀	熔点	N/A
	MSDS	N/A	闪点	N/A

酒石酸福莫特罗用途

Arformoterol tartrate is a long acting beta-adrenoceptor agonist drug indicated for the treatment of chronic obstructive pulmonary disease (COPD). It is sold by Sunovion, under the trade name Brovana, as a solution of arformoterol tartrate to be administered twice daily (morning and evening) by nebulization. It is the active (R,R)-enantiomer of formoterol and was approved by the United States Food and Drug Administration (FDA) on October 6, 2006 for the treatment of COPD.

中文名	酒石酸福莫特罗
英文名	(2R,3R)-2,3-dihydroxybutanedioic acid,N-[2-hydroxy-5-[(1R)-1-hydroxy-2-[[(2R)-1-(4-methoxyphenyl)propan-2-yl]amino]ethyl]phenyl]formamide
中文别名	N-[2-羟基-5-[(1R)-1-羟基-2-[(1R)-2-(4-甲氧基苯基)-1-甲基乙基]氨基]乙基]苯基]甲酰胺-L-(+)-酒石酸盐 \| 酒石酸阿福特罗 \| 酒石酸阿福莫特罗
英文别名	更多

沸点	603.2ºC at 760mmHg
分子式	C₂₃H₃₀N₂O₁₀
分子量	494.492
精确质量	494.190033
PSA	205.88000
LogP	1.20050
蒸汽压	2.12E-15mmHg at 25°C
储存条件	2~8℃

危害码 (欧洲)	Xi

UNII-5P8VJ2I235

(2R,3R)-2,3-Dihydroxybutandisäure--N-{2-hydroxy-5-[(1R)-1-hydroxy-2-{[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino}ethyl]phenyl}formamid(1:1)

(2R,3R)-2,3-Dihydroxysuccinic acid - N-{2-hydroxy-5-[(1R)-1-hydroxy-2-{[(2R)-1-(4-methoxyphenyl)-2-propanyl]amino}ethyl]phenyl}formamide (1:1)

Butanedioic acid, 2,3-dihydroxy-, (2R,3R)-, compd. with formamide, N-[2-hydroxy-5-[(1R)-1-hydroxy-2-[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]- (1:1)

Brovana (TN)

Brovana

(R,R)-Arformoterol tartrate

acide (2R,3R)-2,3-dihydroxybutanedioïque - N-{2-hydroxy-5-[(1R)-1-hydroxy-2-{[(1R)-2-(4-méthoxyphényl)-1-méthyléthyl]amino}éthyl]phényl}formamide (1:1)

UNII:5P8VJ2I235

(R,R)-Formoterol tartrate

N-{2-hydroxy-5-[(1R)-1-hydroxy-2-{[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino}ethyl]phenyl}formamide 2,3-dihydroxybutanedioate (salt)

Arformoterol tartrate (USAN)

Brovana Inhalation Solution

Arformoterol tartrate